Our results showed an association between BTN2A2 and CTLA-4, CD274, HAVCR2, LAG3, PDCD1LG2, PDCD1, and SIGLEC15 (immune checkpoint molecules) in patients with glioma. This evidence concerns the gene PDCD1LG2 and central nervous system cancer.